A Phase II study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
Details
Age
Adult
Type of Study
Treatment
Locations
Cherry Creek Medical Center
Greeley Campus
Harmony Campus
Highlands Ranch Hospital
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
University of Colorado Hospital
Principal Investigator
Alexis Leal, MD
Study ID
Protocol Number: 21-2687
More information available at ClinicalTrials.gov: NCT04963283
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers